Biomarkers for Predicting Anti-Programmed Cell Death-1 Antibody Treatment Effects in Head and Neck Cancer.
Tanaka K, Hirakawa H, Suzuki M, Higa T, Agena S, Hasegawa N, Kawakami J, Toyama M, Higa T, Kinjyo H, Kise N, Kondo S, Maeda H, Ikegami T.
Tanaka K, et al. Among authors: toyama m.
Curr Oncol. 2023 Jun 2;30(6):5409-5424. doi: 10.3390/curroncol30060410.
Curr Oncol. 2023.
PMID: 37366893
Free PMC article.